Commit d25724b2 authored by fisherdaddy's avatar fisherdaddy

chore: update deepseek timeline

parent 58d55369
......@@ -53,10 +53,22 @@
"feature": "性能比肩 OpenAI o1,成本低廉",
"description": "2025年1月20日,DeepSeek推出了推理模型 DeepSeek-R1,并同步开源其模型权重,通过大规模强化学习技术显著提升推理能力,性能媲美顶尖闭源产品,迅速引发全球关注。MIT 许可均可公开下载和商用。"
},
{
"date": "2025年1月27日",
"title": "DeepSeek 在苹果应用商店中美英等157个国家登顶下载榜",
"feature": "",
"description": ""
},
{
"date": "2025年1月28日",
"title": "开源 Janus-Pro",
"feature": "一个新颖的自回归框架,多模态理解与生成的统一",
"description": "Janus-Pro 是 Janus 的升级版本,通过优化训练策略、扩展训练数据和扩大模型规模,在多模态理解和文本到图像的指令跟随能力上都得到了显著提升,同时增强了文本到图像生成的稳定性。"
},
{
"date": "2025年1月31日",
"title": "DeepSeek 日活突破 2000 万",
"feature": "成为全球增长最快的 APP",
"description": "DeepSeek 的 DAU 达到2215万,相当于同期 ChatGPT DAU(5323万)的41.6%,且超越了豆包的1695万日活"
}
]
\ No newline at end of file
......@@ -224,8 +224,8 @@
"description": "Timeline of Anthropic's major product releases and events"
},
"deepSeekTimeline": {
"title": "DeepSeek Product Release",
"description": "Timeline of DeepSeek's major product releases and events"
"title": "DeepSeek Model Release",
"description": "Timeline of DeepSeek's major model releases and events"
},
"drugsList": {
"title": "Imported Original Drug Directory of China",
......
......@@ -224,8 +224,8 @@
"description": "Anthropic 製品リリース時刻表"
},
"deepSeekTimeline": {
"title": "DeepSeek 製品リリース",
"description": "DeepSeek 製品リリース時刻表"
"title": "DeepSeek モデルリリース",
"description": "DeepSeek モデルリリース時刻表"
},
"drugsList": {
"title": "中国輸入オリジナル薬品リスト",
......
......@@ -225,8 +225,8 @@
"description": "Anthropic 제품 출시 일정"
},
"deepSeekTimeline": {
"title": "DeepSeek 제품 출시",
"description": "DeepSeek 제품 출시 일정"
"title": "DeepSeek 모델 출시",
"description": "DeepSeek 모델 출시 일정"
},
"drugsList": {
"title": "중국 수입 원조 약품 목록",
......
......@@ -226,8 +226,8 @@
"description": "Anthropic 公司重要产品及事件发布时间表"
},
"deepSeekTimeline": {
"title": "DeepSeek 产品发布",
"description": "DeepSeek 产品发布时间一览"
"title": "DeepSeek 模型发布",
"description": "DeepSeek 模型发布时间一览"
},
"drugsList": {
"title": "中国进口原研药目录",
......
Markdown is supported
0% or
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment